相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。5-Amino-2-Aroylquinolines as Highly Potent Tubulin Polymerization Inhibitors
Chih-Ying Nien et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
BNC105: A Novel Tubulin Polymerization Inhibitor That Selectively Disrupts Tumor Vasculature and Displays Single-Agent Antitumor Efficacy
Gabriel Kremmidiotis et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Synthesis and biological evaluation of 7-arylindoline-1-benzenesulfonamides as a novel class of potent anticancer agents
Jang-Yang Chang et al.
MEDCHEMCOMM (2010)
A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P)
Dietmar W. Siemann et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Advances on N-Arylation of Indoles by Cross-Coupling Reactions
Hui Xu
MINI-REVIEWS IN ORGANIC CHEMISTRY (2009)
Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumors
Gillian M. Tozer et al.
CANCER RESEARCH (2008)
A novel oral indoline-sulfonamide agent, N-[1-(4-Methoxy-benzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-Isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule
Jing-Ping Liou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
4-and 5-aroylindoles as novel classes of potent antitubulin agents
Jing-Ping Liou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Construction of the Left domain of haplophytine
K. C. Nicolaou et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Organometallic methods for the synthesis and functionalization of azaindoles
Jinhua J. Song et al.
CHEMICAL SOCIETY REVIEWS (2007)
Multi-component syntheses of heterocycles by transition-metal catalysis
Daniel M. D'Souza et al.
CHEMICAL SOCIETY REVIEWS (2007)
Studies of new indole alkaloid coupling methods for the synthesis of haplophytine
Pankaj D. Rege et al.
ORGANIC LETTERS (2006)
Antitubulin agents for the treatment of cancer - a medicinal chemistry update
Neeraj Mahindroo et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2006)
Medicinal chemistry of combretastatin A4: Present and future directions
GC Tron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Novel indolylindazolylmaleimides as inhibitors of protein kinase C-β:: Synthesis, biological activity, and cardiovascular safety
HC Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Pharmaceutical design of antimitotic agents based on combretastatins
HP Hsieh et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
Copper in cross-coupling reactions - The post-Ullmann chemistry
IP Beletskaya et al.
COORDINATION CHEMISTRY REVIEWS (2004)
BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo
CC Kuo et al.
CANCER RESEARCH (2004)
Discovery and development of antimitotic agents that inhibit tubulin polymerisation for the treatment of cancer
Q Li et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2002)
Palladium-catalyzed cross-coupling reactions for the synthesis of 6,8-disubstituted 1,7-naphthyridines:: A novel class of potent and selective phosphodiesterase type 4D inhibitors
R Hersperger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
